JB Chemicals & Pharmaceuticals Limited Market Cap ($4.18 Billion)
Market Cap & Net Worth: JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
JB Chemicals & Pharmaceuticals Limited market cap. JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) has a market capitalization of $4.18 Billion (Rs386.77 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #3913 globally and #178 in its home market, demonstrating a -1.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JB Chemicals & Pharmaceuticals Limited's stock price Rs2408.90 by its total outstanding shares 160558706 (160.56 Million). Also see JBCHEPHARM cash flow conversion for how efficiently the company converts equity into cash flow.
JB Chemicals & Pharmaceuticals Limited Market Cap History (2015–2026)
JB Chemicals & Pharmaceuticals Limited market cap history from 2015 to 2026. Data shows growth from $216.85 Million to $4.18 Billion (30.90% CAGR). Check JBCHEPHARM stock price and chart for real-time trading data and today's change.
Index Memberships
JB Chemicals & Pharmaceuticals Limited is a constituent of 6 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$104.48 Billion | 4.00% | #11 of 20 |
|
NIFTY 500
NIFTY500
|
$3.06 Trillion | 0.14% | #164 of 500 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.11 Trillion | 0.38% | #91 of 400 |
|
NIFTY MNC
NIFTYMNC
|
$217.79 Billion | 1.92% | #15 of 30 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.14 Trillion | 0.13% | #161 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$395.04 Billion | 1.06% | #16 of 250 |
Weight: JB Chemicals & Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
JB Chemicals & Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JB Chemicals & Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore JBCHEPHARM net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.10x
JB Chemicals & Pharmaceuticals Limited's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.59x
JB Chemicals & Pharmaceuticals Limited's market cap is 0.59 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $270.37 Million | $13.09 Billion | $1.84 Billion | 0.02x | 0.15x |
| 2018 | $244.74 Million | $13.82 Billion | $1.38 Billion | 0.02x | 0.18x |
| 2019 | $346.07 Million | $16.08 Billion | $1.93 Billion | 0.02x | 0.18x |
| 2020 | $846.34 Million | $17.41 Billion | $2.72 Billion | 0.05x | 0.31x |
| 2021 | $1.49 Billion | $20.19 Billion | $4.48 Billion | 0.07x | 0.33x |
| 2022 | $1.64 Billion | $24.24 Billion | $3.85 Billion | 0.07x | 0.43x |
| 2023 | $2.79 Billion | $31.17 Billion | $4.10 Billion | 0.09x | 0.68x |
| 2024 | $3.20 Billion | $34.48 Billion | $5.53 Billion | 0.09x | 0.58x |
| 2025 | $3.16 Billion | $38.62 Billion | $6.60 Billion | 0.08x | 0.48x |
| 2026 | $4.18 Billion | $41.48 Billion | $7.09 Billion | 0.10x | 0.59x |
Competitor Companies of JBCHEPHARM by Market Capitalization
Companies near JB Chemicals & Pharmaceuticals Limited in the global market cap rankings as of November 5, 2026. Also see JB Chemicals & Pharmaceuticals Limited balance sheet assets for a full breakdown of the balance sheet.
Key companies related to JB Chemicals & Pharmaceuticals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of JB Chemicals & Pharmaceuticals Limited (2015–2026)
Market capitalization of JB Chemicals & Pharmaceuticals Limited from 2015 to today. Between 2015 and today, JB Chemicals & Pharmaceuticals Limited's market cap moved from $216.85 Million to $ 4.18 Billion, with a yearly change of 30.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs4.18 Billion | +32.38% |
| 2025 | Rs3.16 Billion | -1.33% |
| 2024 | Rs3.20 Billion | +14.63% |
| 2023 | Rs2.79 Billion | +70.21% |
| 2022 | Rs1.64 Billion | +9.90% |
| 2021 | Rs1.49 Billion | +76.45% |
| 2020 | Rs846.34 Million | +144.56% |
| 2019 | Rs346.07 Million | +41.40% |
| 2018 | Rs244.74 Million | -9.48% |
| 2017 | Rs270.37 Million | -3.35% |
| 2016 | Rs279.73 Million | +29.00% |
| 2015 | Rs216.85 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of JB Chemicals & Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.18 Billion USD |
| MoneyControl | $4.18 Billion USD |
| MarketWatch | $4.18 Billion USD |
| marketcap.company | $4.18 Billion USD |
| Reuters | $4.18 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more